Biotech Target N V - Jul 26, 2021 Form 4 Insider Report for Molecular Templates, Inc. (MTEM)

Role
10%+ Owner
Signature
/s/ Daniel Koller
Stock symbol
MTEM
Transactions as of
Jul 26, 2021
Transactions value $
$1,091,656
Form type
4
Date filed
7/28/2021, 12:23 PM
Previous filing
Jul 21, 2021
Next filing
Sep 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTEM Common Stock Purchase $560K +80K +0.82% $7.00* 9.87M Jul 26, 2021 Direct
transaction MTEM Common Stock Purchase $532K +75K +0.76% $7.09* 9.94M Jul 27, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.